A carregar...
Central Nervous System Delivery of the Antipsychotic Olanzapine Induces Hepatic Insulin Resistance
OBJECTIVE: Olanzapine (OLZ) is an atypical antipsychotic whose clinical efficacy is hampered by side effects including weight gain and diabetes. Recent evidence shows that OLZ alters insulin sensitivity independent of changes in body weight and composition. The present study addresses whether OLZ-in...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Diabetes Association
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3279549/ https://ncbi.nlm.nih.gov/pubmed/20682682 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db10-0449 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|